Landmark Drug Pricing Bill Set to Become Law; HP&M Releases Summary Slide Deck
FDA Law Blog
AUGUST 14, 2022
The negotiations will result in a Maximum Fair Price (“MFP”) that the manufacturer must make available to providers furnishing the drug under Medicare Part B or pharmacies dispensing the drug under Part D. The same will be required under state Medicaid and CHIP programs by October 1, 2023.
Let's personalize your content